Recreational Drugs and Stroke Risk: Clinical Evidence on Cannabis
Cannabis stroke risk clinical evidence indicates a 37% increased risk of stroke among users. This finding is critical for stroke prevention strategies, especially in younger populations. Clinicians should integrate cannabis use screening into…
Study Highlights Stroke Risk Linked to Recreational Drugs, Including Among Young Users
This study highlights cannabis stroke risk young users face, revealing significant cerebrovascular dangers linked to recreational drug use. Clinicians should incorporate cannabis use history into stroke risk assessments, especially for younger patients.…
Daily Digest: Last 9 Hours: Stroke Risk From Recreational Drugs and DEA Scheduling Actions — March 08, 2026
A synthesis of 12 recently added cannabis articles — key themes, clinical context, and Dr. Caplan's take.
Schedules of Controlled Substances: Temporary Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I
The DEA temporary placement Schedule I of N-Desethyl Isotonitazene reflects efforts to control emerging synthetic opioids. This scheduling targets substances with no recognized medical use. Clinicians should stay updated on DEA temporary placement…
Importer of Controlled-Biopharmaceutical (2024-20085) DEA1425 Notice
Controlled biopharmaceutical regulations 2024 are essential for importers to maintain DEA compliance. This notice outlines important regulatory updates affecting controlled substance importers. Understanding these regulations supports adherence to…
Schedules of Controlled Substances: Temporary Placement of N-pyrrolidino metonitazene and N-pyrrolidino protonitazene in Schedule I
Nitazene synthetic opioids such as N-pyrrolidino metonitazene and N-pyrrolidino protonitazene have been temporarily placed in Schedule I. These substances pose significant overdose risks and are emerging threats in illicit drug supplies. Clinicians…
Schedules of Controlled Substances: Placement of Ethylphenidate in Schedule I
This article discusses the schedules of controlled substances focusing on ethylphenidate's placement in Schedule I. The scheduling reflects concerns about synthetic stimulants and abuse potential. Clinicians should be aware of regulatory updates on…
Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene in Schedule I
The synthetic opioids schedule I placement of butonitazene, flunitazene, and metodesnitazene highlights emerging public health concerns. These substances have high abuse potential and no accepted medical use. Clinicians should stay informed about these…
Recreational Drugs Triple Stroke Risk in Young People, Study Finds
A recent study highlights recreational drugs stroke risk as tripling in young adults. Cannabis and cocaine use significantly elevate stroke risk in this population. Clinicians should screen for recreational drugs stroke risk when assessing young stroke…
College is hard lmao
The endocannabinoid system does regulate stress response, but cramming at 2 AM with THC is still not a peer-reviewed study method. Via r/trees Further Reading Cannabis NewsRecreational drugs triple the risk of stroke in young people, study finds | The…
